The effects of peroxisome proliferators on protein abundances in mouse liver

Toxicology and Applied Pharmacology

Volumn 137, Issue 1, 1996, Pages 75-89

  Anderson, N Leigh ^a   Esquer Blasco, Ricardo ^a   Richardson, Frank ^a   Foxworthy, Patricia ^b   Eacho, Patrick ^b  

^a Large Scale Biology Corporation   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 HYDROXY 3 PROPYL 4 [[4 (1H TETRAZOL 5 YLMETHYL)PHENOXY]METHYL]PHENYL]ETHANONE; CLOFIBRIC ACID; LIVER PROTEIN; NAFENOPIN; PEROXISOME PROLIFERATOR; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PIRINIXIC ACID; TOMELUKAST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

EID: 0002556020     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0059     Document Type: Article

References (30)

1. Amri, E.-Z., Bonino, F., Ailhaud, G., and Grimaldi, P. (1994). SWISS-PROT Sequence Accession No. P35396, unpublished.
2. Anderson, N. L., Esquer-Blasco, R., and Anderson, N. G. (1994). Two-dimensional electrophoresis as applied to problems of in vitro and in vivo toxicology. In Methods in Toxicology: In Vitro Toxicity Indicators (C. A. Tyson and J. M. Frazier, Eds.), pp. 463-473. Academic Press, New York.
3. Anderson, N. L., and Anderson, N. G. (1978a). Analytical techniques for cell fractions. XXII. Two-dimensional analysis of serum and tissue proteins: Multiple gradient-slab electrophoresis. Anal. Biochem. 85, 341-354.
4. Anderson, N. G., and Anderson, N. L. (1978b). Analytical techniques for cell fractions. XXI. Two-dimensional analysis of serum and tissue proteins: Multiple isoelectric focusing. Anal. Biochem. 85, 331-340.
5. Anderson, N. L., Giere, F. A., Nance, S. L., Gemmell, M. A., Tollaksen, S. L., and Anderson, N G. (1987). Effects of toxic agents at the protein level: Quantitative measurement of 213 mouse liver proteins following xenobiotic treatment. Fundam. Appl. Toxicol. 8, 39-50.
6. Anderson, N. L., Esquer-Blasco, R., Hofmann, J.-P., and Anderson, N. G. (1991). A two-dimensional gel database of rat liver proteins useful in gene regulation and drug effects studies. Electrophoresis 12, 907-930.
7. Banner, C. D., Gottlicher, M., Widmark, E., Sjovall, J., Rafter, J. J., and Gustafsson, J. A. (1993). A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: Characterization of peroxisome proliferator-activated receptor activators in plasma. J. Lipid Res. 34, 1583-1591.
8. Bardot, O., Aldridge, T. C., Latruffe, N., and Green, S. (1993). PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun. 192, 37-45.
9. 1 mice. Fundam. Appl. Tox. 15, 676-682.
10. Chen, F., Law, S. W., and O'Malley, B. W. (1993). Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochem. Biophys. Res. Commun. 196(2), 671-677.
11. Eacho, P. I., Foxworthy, P. S., Johnson, W. D., Hoover, D. M., and White, S. L. (1986). Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyphenone in rats and comparison with other species. Toxicol. Appl. Pharmacol. 83, 430-437.
12. Eacho, P. I., Foxworthy, P. S., Dillard, R. D., Whitesitt, C. A., Herron, D. K., and Marshall, W. S. (1989). Induction of peroxisomal β-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: Structure-activity relationships. Toxicol. Appl. Pharmacol. 100, 177-184.
13. Gearing, K. L., Crickmore, A., and Gustafsson, J. A. (1994). Structure of the mouse peroxisome proliferator activated receptor alpha gene. Biochem. Biophys. Res. Commun. 199, 255-263.
14. Gearing, K. L., Gottlicher, M., Teboul, M., Widmark, E., and Gustafsson, J. A. (1993). Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci, USA 90, 1440-1444.
15. Giometti, C. S., Taylor, J., Gemmell, M. A., Tollaksen, S. L., Lalwani, N. D., and Reddy, J. K. (1991a). A comparative study of the effects of clofibrate, ciprofibrate, WY-14,643, and di-(2-ethylhexyl)-phthalate on liver protein expression in mice. Appl. Theor. Electrophoret. 2, 101-107.
16. Giometti, C. S., Taylor, J., Gemmell, M. A., Tollaksen, S. L., Lalwani, N. D., and Reddy, J. K. (1991b). Quantitative Changes in Sets of Proteins as Markers of Biological Response, pp. 119-128. New Horizons in Biological Dosimetry, Wiley-Liss.
17. Grant, D. F., Storms, D. H., and Hammock, B. D. (1993). Molecular cloning and expression of murine liver soluble epoxide hydrolase. J. Biol. Chem. 268, 17628-17633.
18. Issemann, I., and Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650.
19. Issemann, I., Prince, R. A., Tugwood, J. D., and Green, S. (1993a). The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor. Biochimie 75, 251-256.
20. Issemann, I., Prince, R. A., Tugwood, J. D., and Green, S. (1993b). The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol. 11, 37-47.
21. Knehr, M., Thomas, H., Arand, M., Gebel, T., Zeller, H. D., and Oesch, F. (1993). Isolation and characterization of a cDNA encoding rat liver cytosolic epoxide hydrolase and its functional expression in Escherichia coli. J. Biol. Chem. 268, 17623-17627.
22. Lazarow, P. B. (1981). Assay of peroxisomal β-oxidation of fatty acids. In Methods of Enzymology (J. M. Lowenstein, Ed.), Vol. 72, pp. 315-319. Academic Press, New York.
23. Motojima, K., and Goto, S. (1992). Rat liver BiP/GRP78 is down-regulated by a peroxisome proliferator, ciprofibrate. FEBS Lett. 308(2): 207-210.
24. Sher, T., Yi, H. F., McBride, O. W., and Gonzalez, F. I. (1993). cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32, 5598-5604.
25. Reddy, J. K., and Lalwani, N. D. (1983). Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers. CRC Crit Rev. Toxicol. 12, 1-58.
26. Rosenfeld, J., Capdevielle, J., Guillemot, J. C., and Ferrara, P. (1992). Ingel digestion of proteins for internal sequence analysis after one-or two-dimensional gel electrophoresis. Anal. Biochem. 203, 173-179.
27. Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., Green, S. (1992). The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11, 433-439.
28. Watanabe, T., Lalwani, N. D., and Reddy, J. K. (1985). Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)-phthalate. Biochem. J. 227, 767-775.
29. Witzmann, F. A., Jarnot, B. M., Parker, D. N., and Clack, J. W. (1994). Modification of immunoglobulin heavy chain binding protein (BiP/ Grp78) following exposure to structurally diverse peroxisome proliferators. Fundam. Appl. Tox. 23, 1-8.
30. Zhu, Y., Alvares, K., Huang, Q., Rao, M. S., and Reddy, J. K. (1993). Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem. 268, 26817-26820.